In the past couple of months, the healthcare and pharmaceutical sectors have undergone significant regulatory and policy shifts, highlighting a sustained focus on transparency, quality assurance, and ...
Published On: 17/06/2020
Practice Area: Capital Markets & International Offerings, Corporate & Commercial
Authors:

Manan Lahoty



joins




